| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.7 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |